Host Plasminogen Activator Inhibitor-1 Promotes Human Skin Carcinoma Progression in a Stage-Dependent Manner

Catherine Maillard; Maud Jost; Maria Unni Rømer; Nils Brünner; Xavier Houard; Annabelle Lejeune; Carine Munaut; Khalid Bajou; Laurence Mélen; Keld Danø; Peter Carmeliet; Norbert E. Fusenig; Jean Michel Foidart; Agnès Noël

doi:10.1593/neo.04406

Related publications

Article2003

Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism.

Cristina Roca, Luca Primo, Donatella Valdembri, Anna Cividalli, Paul Declerck, Peter Carmeliet, P. Gabriele, Federico Bussolino

Article1998

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization

Khalid Bajou, Agnès Noël, Robert D. Gerard, Véronique Masson, Nils Brünner, Claus Holst‐Hansen, Mihaela Skobe, Norbert E. Fusenig, Peter Carmeliet, D Collen, J.M. Foidart

Article2014

Age-Dependent Neonatal Intracerebral Hemorrhage in Plasminogen Activator Inhibitor 1 Knockout Mice

Philippe Leroux, Priscilla L. Omouendze, Vincent Roy, Nathalie Dourmap, Bruno J. Gonzalez, Carole Brasse‐Lagnel, Peter Carmeliet, Isabelle Leroux‐Nicollet, Stéphane Marret

Article1998

Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.

David J. Pinsky, Hui Liao, Charles A. Lawson, Shi Fang Yan, J Chen, Peter Carmeliet, David J. Loskutoff, D Stern

Article2002

The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

Laetitia Devy, Silvia Blacher, Christine Grignet‐Debrus, Khalid Bajou, Véronique Masson, Robert D. Gerard, Ann Gils, Geert Carmeliet, Peter Carmeliet, Paul Declerck, Agnès Noël, Jean-Michel Foidart